GlassScriptPhysician profile
George T Rizk
NPI 1730145459
$2,044.21
in general payments reported to CMS, 2019-2025
17 companies · $155 in 2025
The $155 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $794 · 2020: $95.16 · 2021: $211 · 2022: $84.82 · 2023: $156 · 2024: $550 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $860.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $859.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $482.33 | 2019-2025 | Lifevest |
| Edwards Lifesciences Corporation | $256.20 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $222.92 | 2019-2023 | Eliquis, Camzyos |
| Amgen INC. | $206.77 | 2019-2022 | |
| Abbott Laboratories | $194.61 | 2019-2024 | Cardiomems, Diamondback Peripheral, Perclose Proglide |
| Boston Scientific Corporation | $117.91 | 2019-2024 | Watchman |
| Medtronic, INC. | $113.03 | 2025 | Micra |
| Astrazeneca Pharmaceuticals LP | $79.89 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $68.11 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $63.64 | 2019-2020 | |
| Siemens Medical Solutions USA, INC. | $62.81 | 2019 | |
| Pfizer INC. | $54.75 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $37.76 | 2019 | |
| Sanofi-Aventis U.S. LLC | $35.07 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $19.25 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microvention, INC. | $14.70 | 2019 | |
| Philips North America LLC | $14.46 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Rizk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.